Intractable
skin defects, which involve excessive inflammation
and bacterial infections, caused by burns, trauma, and diabetes are
a major challenge for clinicians. Compared with traditional skin transplantation,
tissue-engineered skin has the advantages of a wide range of sources,
prominent biological activity, and no damage to the donor area during
the operation. Therefore, an effective wound-healing mat with antibacterial,
anti-inflammatory, and microvascularization bioactivities is urgent
to be developed. In this study, we have synthesized a poly(ester-urethane)urea/silk
fibroin/magnolol nanofibrous composite mat (PSM) through electrospinning
and post-hydrogen bond cross-linking. The results show that the hybrid
magnolol has no adverse effect on the microstructure, porosity, wettability,
and mechanical properties of PSM. Antibacterial experiments and cytocompatibility
in vitro have proved that the addition of magnolol significantly improves
the antibacterial ability and promotes cell adhesion and proliferation
of PSM. In addition, the wound model of rat back and H&E staining,
Masson trichrome staining, and CD31 and CD68 immunofluorescence staining
were performed for evaluating the therapeutic efficiency of PSM. All
the results show that the better wound treatment effect of magnolol
hybrid nanofibrous mats in infectious skin tissue defected repair
indicates their great potential for wound healing clinically.